The Latest: US health insurees may receive higher rebates

WASHINGTON — U.S. health insurance customers may receive higher premium rebates than normal later this year partly because insurers had less care to cover after COVID-19 arrived in 2020.

Some individual insurance customers could receive premium credits or rebates of nearly $300 on average, according to an analysis of government data from the non-profit Kaiser Family Foundation.

The Affordable Care Act requires insurers to give customers refunds or premium credits if they don’t spend certain percentages of the premiums they collect on care and costs related to it.

Kaiser’s analysis noted that last year hospitals and other care providers canceled surgeries and non-essential care early in the pandemic and then during subsequent COVID-19 spikes.

Kaiser Vice President Cynthia Cox said nearly half of customers in the individual market receive these annual rebates. Some people with employer-sponsored coverage also may get rebates that they share with their company.

Rebate totals will be finalized later this year. They generally are then delivered by the end of September. The totals will vary by market and depend on factors like whether an insurer has already offered premium breaks to counter the drop in care.



VACCINES: More than 122.2 million people, or 36.8% of the U.S. population, have received at least one dose of a coronavirus vaccine, according to the Centers for Disease Control and Prevention. Some 75.3 million people, or 22.7% of the population, have completed their vaccination.

CASES: The seven-day rolling average for daily new cases in the U.S. rose over the past two weeks 65,785.4 on March 29 to 68,959.6 on Monday, according to Johns Hopkins University.

DEATHS: The seven-day rolling average for daily new deaths in the U.S. did not increase over the past two weeks going from 1,001 on March 29 to 962.4 on Monday, according to Johns Hopkins University.

— US suggests ‘pause’ on Johnson & Johnson shots over blood clot reports

— South Africa halts J&J vaccine shots; Europe rollout delayed

— Muslims open Ramadan with communal prayers in socially distanced contrast to empty mosques of a year ago

India reels from explosive virus surge, affecting world vaccine supply

— Follow AP’s pandemic coverage at and



WASHINGTON — The nation’s capital city joined a growing list of states in suspending the Johnson & Johnson COVID-19 vaccine that’s become the focus of a federal examination of rare blood clots.

District of Columbia health director Dr. LaQuandra Nesbitt says she’s not aware of any cases of dangerous blood clots among the 16,000 Washingtonians who had received the J&J one-dose vaccine before the temporary halt recommended by federal health authorities.

“This pause means that the system is working properly,” Nesbitt says.

J&J said in a statement Tuesday it was aware of the reports of blood clots, but that no link to its vaccine had been established.

A CDC committee will meet Wednesday to discuss the cases. The FDA has launched an investigation into the cause of the clots and low platelet counts. There have been six reported clots among the 6.8 million shots administered.

U.S. health authorities cautioned doctors against using a typical clot treatment, the blood-thinner heparin. “In this setting, administration of heparin may be dangerous and alternative treatments need to be given,” the FDA and CDC say.

Washington state, Idaho, California, Alabama, Wisconsin, Colorado and Nevada are among the states that have temporarily halted or have recommended pausing the use of the Johnson & Johnson shot amid the investigation.


BERLIN — South Africa has suspended giving the Johnson & Johnson vaccine as a “precautionary measure” following the FDA decision in the U.S. to pause the use of the vaccine while rare blood clots are examined.

All six cases were in women between ages 18 to 48, including one who died. The unusual clots occurred six to 13 days after vaccination.

South Africa has given more than 289,000 shots of the J&J vaccine to the country’s health workers without any reports of blood clots, Health Minister Dr. Zweli Mkhize says.

He says South Africa is halting the use of the J&J doses “out of an abundance of caution.” He expects the questions regarding the J&J vaccine should “be cleared within a matter of days.”

Recently, the blood clot reports prompted several European Union countries in the 27-nation bloc to limit the AstraZeneca vaccine to older age groups.


OTTAWA, Ontario — The Public Health Agency of Canada says it has received a report of an adverse event involving blood clots after someone in Canada received the AstraZeneca vaccine.

This is the first such reported case in Canada. The federal agency says the person is recovering at home. The vaccine was the one produced at the Serum Institute of India.

The AstraZeneca vaccine is approved for those 55 and over in Canada. Several European countries decided in recent weeks to limit their use of the AstraZeneca vaccine to older people because of concerns the vaccine may be linked to rare blood clots in younger populations.


WASHINGTON — Dr. Anthony Fauci says Americans who’ve recently received a Johnson & Johnson COVID-19 vaccine shouldn’t be anxious about the “pause” in shots because of reports of blood clots.

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention called for the pause Tuesday to investigate six reports of potentially dangerous blood clots, among more than 6.8 million doses administered.

The nation’s top infectious disease expert says, “It’s less than one in a million.” Fauci adds people should “pay attention” to symptoms associated with the blood clots, particularly between one and three weeks after the shot.

The White House was first informed of the announcement Monday night, coronavirus coordinator Jeff Zients says. He defended the administration’s notification to states, saying, “there was no heads up here.”

Fauci says the pause by regulators is a “testimony to how seriously we take safety.”


ANKARA, Turkey — Turkish President Recep Tayyip Erdogan announced a partial lockdown during the first two weeks of the Muslim month of Ramadan to curb coronavirus infections reaching record levels.

In a televised address following a Cabinet meeting, Erdogan says the government was re-imposing bans on intercity travel, barring people above age 65 and those below 18 from using public transport, re-adjusting public sector shifts and working hours, closing down sports and leisure centers and expanding nighttime curfew hours to combat the surge in infections.

Weddings, engagement parties and other crowded gatherings will be barred until after a holiday that follows the month of Ramadan. He warned of stricter measures should the new restrictions fail to bring the infections down.

Turkey’s single-day infections increased five-fold since March to reach above 50,000. Last week, the country hit a record 55,941 confirmed cases. On Tuesday, the health ministry reported 59,187 new infections, the highest daily number since the start of the pandemic. It also reported 273 confirmed deaths.


BERLIN — Johnson & Johnson says it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe into rare blood clots.

The announcement came after regulators in the U.S. say they were recommending a “pause” in administration of the single-dose shot to investigate reports of potentially dangerous blood clots.

“We have been reviewing these cases with European health authorities,” the company said. “We have made the decision to proactively delay the rollout of our vaccine in Europe.”

The delay is another blow to vaccination drives in European Union member nations, which have been plagued by supply shortages, logistical problems and concerns over unusual blood clots in a small number of people who received the AstraZeneca vaccine.

The blood clot reports prompted several countries in the 27-nation bloc to limit the AstraZeneca vaccine to older age groups, who are more at risk from serious illness when infected with the coronavirus.

The European Medicines Agency, the EU’s equivalent to the FDA, says it is having its safety committee investigate these J&J blood clot cases “and will decide whether regulatory action may be necessary.”

The EU ordered 200 million doses of the Johnson & Johnson vaccine in 2021. Britain ordered 30 million doses of the J& J shots, although U.K. regulators have not yet approved its use.


WASHINGTON — The Pentagon says it is immediately pausing the use of the single-dose Johnson & Johnson COVID-19 vaccine, amid reports of potentially dangerous blood clots.

The announcement came as Johnson & Johnson says it is delaying the rollout of its vaccine in Europe, and U.S. regulators recommended a “pause” in the administration of the shot.

Pentagon spokesman John Kirby says the department is reviewing its distribution of vaccines to address the issue and will continue to provide other shots to defense personnel.

In a joint statement, the Centers for Disease Control and Prevention and the Food and Drug Administration announced it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

Dr. Janet Woodcock, the Food and Drug Administration’s acting commissioner, said earlier Tuesday the agency “expects it to be a matter of days for this pause.”

Regulators say they want to educate patients and medical professionals about spotting and treating the clots. The clots were observed along with reduced platelet counts, making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”


PARIS — France suspended all flights from Brazil on Tuesday amid mounting fears over the particularly contagious coronavirus variant that has been sweeping the South American country.

Prime Minister Jean Castex announced the suspension to parliament.

Although France has seen comparatively few known cases of the P.1 variant striking Brazil, the ravages it is causing in Latin America’s largest nation are increasingly raising alarm bells in France.

Castex noted travelers from Brazil already needed to test negative for the coronavirus before their departure and upon arrival in France and quarantine for 10 days. But the government has been facing mounting calls from health experts for a flight suspension to further limit potential spread.

The country is struggling with another wave of coronavirus infections and hospitalizations that is straining hospitals in Paris and elsewhere.

France has reported 5.1 million coronavirus cases since the pandemic began, the highest number in Europe, and 99,000 confirmed deaths.


NEW DELHI — India is experiencing its worst pandemic surge, with average daily infections exceeding 143,000 in the past week.

The spike is particularly alarming because India is a major vaccine producer and a critical supplier to the U.N.-backed initiative that aims to help distribute shots fairly. Already the rise in cases has forced India to focus on satisfying its domestic demand and delay deliveries elsewhere.

When infections began plummeting in India in September, many concluded the worst had passed. Masks and social distancing were abandoned, while the government gave mixed signals about the level of risk. Then cases began rising again in February.


WASHINGTON — A White House coronavirus adviser says the pause on the Johnson & Johnson vaccine by the FDA and CDC “will not have a significant impact” on the overall vaccination plan in the U.S.

Jeff Zients, the White House COVID-19 Response Coordinator, says “We are working now with our state and federal partners to get anyone scheduled for a J&J vaccine quickly rescheduled for a Pfizer or Moderna vaccine.”

Zients says in a statement the Johnson & Johnson vaccine makes up less than 5% of the recorded shots in arms in the United States so far.

He adds that’s more than enough supply to continue the current pace of vaccinations of 3 million shots per day and meet the President’s goal of 200 million shots by his 100th day in office.


LONDON — Britain has begun offering coronavirus vaccinations to anyone over 45 after hitting its target of giving at least one dose to everyone over 50 by the middle of April.

The government says all residents over 50, health care workers and people with serious medical conditions had been offered a shot, and about 95% have received one.

As a result, the government launched the second phase of its inoculation campaign on Tuesday by expanding eligibility to people 45 to 49.

Despite the good news, British Prime Minister Boris Johnson warned the U.K. would inevitably see “more hospitalization and deaths” as it emerges from lockdown.


MADRID — Spanish Prime Minister Pedro Sánchez says the benefits of taking the Johnson & Johnson vaccine are greater than the risks.

Sánchez was asked about U.S. move to pause the J&J vaccine during his presentation of Spain’s plans for the EU recovery funds.

The prime minister says he would have to inform himself of the situation, but “we have to all be aware that all the vaccines being administered to the Spanish population, and the European, as well as American populations, are safe.”

“They all count on all the guarantees they need, and the balance between benefit and risk is clearly on the side of taking the vaccine,” Sánchez says.

Spain is expecting to receive 300,000 doses of the J&J vaccine on Wednesday, the first delivery of the shots made by the Janssen subsidiary. The country had planned to prioritize people ages 70 and 79 to receive the single-dose vaccine.